BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kamada T, Hata J, Sugiu K, Kusunoki H, Ito M, Tanaka S, Inoue K, Kawamura Y, Chayama K, Haruma K. Clinical features of gastric cancer discovered after successful eradication of Helicobacter pylori: results from a 9-year prospective follow-up study in Japan. Aliment Pharmacol Ther. 2005;21:1121-1126. [PMID: 15854174 DOI: 10.1111/j.1365-2036.2005.02459.x] [Cited by in Crossref: 83] [Cited by in F6Publishing: 77] [Article Influence: 4.9] [Reference Citation Analysis]
Number Citing Articles
1 Sugano K. Premalignant conditions of gastric cancer: Gastric precancerous conditions. J Gastroenterol Hepatol 2013;28:906-11. [DOI: 10.1111/jgh.12209] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
2 Kamada T, Sato M, Tokutomi T, Watanabe T, Murao T, Matsumoto H, Manabe N, Ito M, Tanaka S, Inoue K, Shiotani A, Akiyama T, Hata J, Haruma K. Rebamipide improves chronic inflammation in the lesser curvature of the corpus after Helicobacter pylori eradication: a multicenter study. Biomed Res Int 2015;2015:865146. [PMID: 26060821 DOI: 10.1155/2015/865146] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
3 Yoon K, Kim N. Reversibility of Atrophic Gastritis and Intestinal Metaplasia by Eradication of Helicobacter pylori. Korean J Gastroenterol 2018;72:104. [DOI: 10.4166/kjg.2018.72.3.104] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Matsumura S, Dohi O, Yamada N, Harusato A, Yasuda T, Yoshida T, Ishida T, Azuma Y, Kitae H, Doi T, Hirose R, Inoue K, Yoshida N, Kamada K, Uchiyama K, Takagi T, Ishikawa T, Konishi H, Morinaga Y, Kishimoto M, Yagi N, Naito Y, Itoh Y. Improved Visibility of Early Gastric Cancer after Successful Helicobacter pylori Eradication with Image-Enhanced Endoscopy: A Multi-Institutional Study Using Video Clips. J Clin Med 2021;10:3649. [PMID: 34441946 DOI: 10.3390/jcm10163649] [Reference Citation Analysis]
5 Tahara T, Shibata T, Horiguchi N, Kawamura T, Okubo M, Ishizuka T, Nagasaka M, Nakagawa Y, Ohmiya N. A Possible Link between Gastric Mucosal Atrophy and Gastric Cancer after Helicobacter pylori Eradication. PLoS One 2016;11:e0163700. [PMID: 27706195 DOI: 10.1371/journal.pone.0163700] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
6 Sakitani K, Nishizawa T, Arita M, Yoshida S, Kataoka Y, Ohki D, Yamashita H, Isomura Y, Toyoshima A, Watanabe H, Iizuka T, Saito Y, Fujisaki J, Yahagi N, Koike K, Toyoshima O. Early detection of gastric cancer after Helicobacter pylori eradication due to endoscopic surveillance. Helicobacter. 2018;23:e12503. [PMID: 29924436 DOI: 10.1111/hel.12503] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
7 Yoshifuku Y, Sanomura Y, Oka S, Kuroki K, Kurihara M, Mizumoto T, Urabe Y, Hiyama T, Tanaka S, Chayama K. Clinical Usefulness of the VS Classification System Using Magnifying Endoscopy with Blue Laser Imaging for Early Gastric Cancer. Gastroenterol Res Pract 2017;2017:3649705. [PMID: 28596787 DOI: 10.1155/2017/3649705] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
8 Kobayashi M, Sato Y, Terai S. Endoscopic surveillance of gastric cancers after Helicobacter pylori eradication. World J Gastroenterol 2015; 21(37): 10553-10562 [PMID: 26457015 DOI: 10.3748/wjg.v21.i37.10553] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
9 Maehata Y, Nakamura S, Esaki M, Ikeda F, Moriyama T, Hida R, Washio E, Umeno J, Hirahashi M, Kitazono T. Characteristics of Primary and Metachronous Gastric Cancers Discovered after Helicobacter pylori Eradication: A Multicenter Propensity Score-Matched Study. Gut Liver. 2017;11:628-634. [PMID: 28395508 DOI: 10.5009/gnl16357] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
10 Mabe K, Takahashi M, Oizumi H, Tsukuma H, Shibata A, Fukase K, Matsuda T, Takeda H, Kawata S. Does Helicobacter pylori eradication therapy for peptic ulcer prevent gastric cancer? World J Gastroenterol 2009; 15(34): 4290-4297 [PMID: 19750572 DOI: 10.3748/wjg.15.4290] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.0] [Reference Citation Analysis]
11 Dohi O, Yagi N, Naito Y, Fukui A, Gen Y, Iwai N, Ueda T, Yoshida N, Kamada K, Uchiyama K, Takagi T, Konishi H, Yanagisawa A, Itoh Y. Blue laser imaging-bright improves the real-time detection rate of early gastric cancer: a randomized controlled study. Gastrointest Endosc. 2019;89:47-57. [PMID: 30189197 DOI: 10.1016/j.gie.2018.08.049] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 8.0] [Reference Citation Analysis]
12 Takenaka R, Okada H, Kato J, Makidono C, Hori S, Kawahara Y, Miyoshi M, Yumoto E, Imagawa A, Toyokawa T, Sakaguchi K, Shiratori Y. Helicobacter pylori eradication reduced the incidence of gastric cancer, especially of the intestinal type. Aliment Pharmacol Ther. 2007;25:805-812. [PMID: 17373919 DOI: 10.1111/j.1365-2036.2007.03268.x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 80] [Article Influence: 5.9] [Reference Citation Analysis]
13 Kobayashi M, Hashimoto S, Nishikura K, Mizuno K, Takeuchi M, Sato Y, Ajioka Y, Aoyagi Y. Magnifying narrow-band imaging of surface maturation in early differentiated-type gastric cancers after Helicobacter pylori eradication. J Gastroenterol. 2013;48:1332-1342. [PMID: 23420575 DOI: 10.1007/s00535-013-0764-7] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 5.1] [Reference Citation Analysis]
14 Kobayashi M, Hashimoto S, Mizuno K, Takeuchi M, Sato Y, Watanabe G, Ajioka Y, Azumi M, Akazawa K, Terai S. Therapeutic or spontaneous Helicobacter pylori eradication can obscure magnifying narrow-band imaging of gastric tumors. Endosc Int Open. 2016;4:E665-E672. [PMID: 27556076 DOI: 10.1055/s-0042-105869] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
15 Lee S. Helicobacter pylori Infection and the Kyoto Classification of Gastritis. Korean J Helicobacter Up Gastrointest Res 2019;19:81-7. [DOI: 10.7704/kjhugr.2019.19.2.81] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
16 Obayashi Y, Kawano S, Sakae H, Abe M, Kono Y, Kanzaki H, Iwamuro M, Kawahara Y, Tanaka T, Yanai H, Okada H. Risk Factors for Gastric Cancer after the Eradication of Helicobacter pylori Evaluated Based on the Background Gastric Mucosa: A Propensity Score-matched Case-control Study. Intern Med 2021;60:969-76. [PMID: 33162475 DOI: 10.2169/internalmedicine.5486-20] [Reference Citation Analysis]
17 Iijima K, Koike T, Abe Y, Ara N, Uno K, Imatani A, Ohara S, Shimosegawa T. Alteration of correlation between serum pepsinogen concentrations and gastric acid secretion after H. pylori eradication. J Gastroenterol 2009;44:819-25. [DOI: 10.1007/s00535-009-0066-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
18 Strickertsson JA, Desler C, Martin-Bertelsen T, Machado AM, Wadstrøm T, Winther O, Rasmussen LJ, Friis-Hansen L. Enterococcus faecalis infection causes inflammation, intracellular oxphos-independent ROS production, and DNA damage in human gastric cancer cells. PLoS One 2013;8:e63147. [PMID: 23646188 DOI: 10.1371/journal.pone.0063147] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
19 Tashiro J, Miwa J, Tomita T, Matsubara Y, Oota Y. GASTRIC CANCER DETECTED AFTER HELICOBACTER PYLORI ERADICATION. Dig Endosc 2007;19:167-73. [DOI: 10.1111/j.1443-1661.2007.00749.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
20 Kodama M, Murakami K, Okimoto T, Abe H, Sato R, Ogawa R, Mizukami K, Shiota S, Nakagawa Y, Soma W. Histological characteristics of gastric mucosa prior to Helicobacter pylori eradication may predict gastric cancer. Scand J Gastroenterol. 2013;48:1249-1256. [PMID: 24079881 DOI: 10.3109/00365521.2013.838994] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
21 Shinozaki S, Osawa H, Hayashi Y, Lefor AK, Yamamoto H. Linked color imaging for the detection of early gastrointestinal neoplasms. Therap Adv Gastroenterol 2019;12:1756284819885246. [PMID: 31700545 DOI: 10.1177/1756284819885246] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
22 Kong YJ, Yi HG, Dai JC, Wei MX. Histological changes of gastric mucosa after Helicobacter pylori eradication: A systematic review and meta-analysis. World J Gastroenterol 2014; 20(19): 5903-5911 [PMID: 24914352 DOI: 10.3748/wjg.v20.i19.5903] [Cited by in CrossRef: 57] [Cited by in F6Publishing: 42] [Article Influence: 7.1] [Reference Citation Analysis]
23 Doorakkers E, Lagergren J, Engstrand L, Brusselaers N. Eradication of Helicobacter pylori and Gastric Cancer: A Systematic Review and Meta-analysis of Cohort Studies. J Natl Cancer Inst. 2016;108. [PMID: 27416750 DOI: 10.1093/jnci/djw132] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 7.7] [Reference Citation Analysis]
24 Kosunen TU, Pukkala E, Sarna S, Seppälä K, Aromaa A, Knekt P, Rautelin H. Gastric cancers in Finnish patients after cure of Helicobacter pylori infection: A cohort study. Int J Cancer. 2011;128:433-439. [PMID: 20309944 DOI: 10.1002/ijc.25337] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
25 Toyoshima O, Yamaji Y, Yoshida S, Matsumoto S, Yamashita H, Kanazawa T, Hata K. Endoscopic gastric atrophy is strongly associated with gastric cancer development after Helicobacter pylori eradication. Surg Endosc. 2017;31:2140-2148. [PMID: 27604367 DOI: 10.1007/s00464-016-5211-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
26 Majima A, Handa O, Naito Y, Dohi O, Okayama T, Yoshida N, Kamada K, Katada K, Uchiyama K, Ishikawa T. Early-Stage Gastric Cancer Can Be Found in Improved Atrophic Mucosa over Time from Successful Helicobacter pylori Eradication. Digestion. 2017;95:194-200. [PMID: 28288471 DOI: 10.1159/000460245] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
27 Shichijo S, Hirata Y. Characteristics and predictors of gastric cancer after Helicobacter pylori eradication. World J Gastroenterol 2018; 24(20): 2163-2172 [PMID: 29853734 DOI: 10.3748/wjg.v24.i20.2163] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 19] [Article Influence: 5.8] [Reference Citation Analysis]
28 Lu YF, Lyu B. Current situation and prospect of artificial intelligence application in endoscopic diagnosis of Helicobacter pylori infection. Artif Intell Gastrointest Endosc 2021; 2(3): 50-62 [DOI: 10.37126/aige.v2.i3.50] [Reference Citation Analysis]
29 Saka A, Yagi K, Nimura S. Endoscopic and histological features of gastric cancers after successful Helicobacter pylori eradication therapy. Gastric Cancer. 2016;19:524-530. [PMID: 25752268 DOI: 10.1007/s10120-015-0479-y] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 6.4] [Reference Citation Analysis]
30 Park YH, Kim N. Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer. J Cancer Prev. 2015;20:25-40. [PMID: 25853101 DOI: 10.15430/jcp.2015.20.1.25] [Cited by in Crossref: 124] [Cited by in F6Publishing: 68] [Article Influence: 17.7] [Reference Citation Analysis]
31 Sekine H, Iijima K, Koike T, Abe Y, Imatani A, Kato K, Ohara S, Shimosegawa T. Regional differences in the recovery of gastric acid secretion after Helicobacter pylori eradication: evaluations with Congo red chromoendoscopy. Gastrointestinal Endoscopy 2006;64:678-85. [DOI: 10.1016/j.gie.2006.01.073] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
32 Roesler BM, Costa SC, Zeitune JM. Eradication Treatment of Helicobacter pylori Infection: Its Importance and Possible Relationship in Preventing the Development of Gastric Cancer. ISRN Gastroenterol. 2012;2012:935410. [PMID: 22778979 DOI: 10.5402/2012/935410] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
33 Yoon H. Atrophic Gastritis and Intestinal Metaplasia. In: Kim N, editor. Helicobacter pylori. Singapore: Springer; 2016. pp. 515-20. [DOI: 10.1007/978-981-287-706-2_52] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
34 Inoue K, Fujisawa T, Haruma K. Assessment of Degree of Health of the Stomach by Concomitant Measurement of Serum Pepsinogen and Serum Helicobacter Pylori Antibodies. Int J Biol Markers 2010;25:207-12. [DOI: 10.5301/jbm.2010.6087] [Cited by in Crossref: 24] [Article Influence: 6.0] [Reference Citation Analysis]
35 Tulassay Z, Stolte M, Engstrand L, Butruk E, Malfertheiner P, Dítê P, Tchernev K, Wong BC, Gottlow M, Eklund S, Wrangstadh M, Herszényi L, Nagy P; HELIX Study Investigators. Twelve-month endoscopic and histological analysis following proton-pump inhibitor-based triple therapy in Helicobacter pylori-positive patients with gastric ulcers. Scand J Gastroenterol 2010;45:1048-58. [PMID: 20509752 DOI: 10.3109/00365520903575737] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
36 Kodama M, Okimoto T, Mizukami K, Abe H, Ogawa R, Okamoto K, Shuto M, Matsunari O, Hirashita Y, Sato R, Abe T, Nagai T, Arita T, Murakami K. Endoscopic and Immunohistochemical Characteristics of Gastric Cancer with versus without Helicobacter Pylori Eradication. Digestion 2018;97:288-97. [PMID: 29514141 DOI: 10.1159/000485504] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
37 Akazawa Y, Ueyama H, Yao T, Komori H, Takeda T, Matsumoto K, Matsumoto K, Asaoka D, Hojo M, Watanabe S, Nagahara A. Usefulness of Demarcation of Differentiated-Type Early Gastric Cancers after Helicobacter pylori Eradication by Magnifying Endoscopy with Narrow-Band Imaging. Digestion 2018;98:175-84. [PMID: 29870997 DOI: 10.1159/000489167] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
38 Sakitani K, Hirata Y, Suzuki N, Shichijo S, Yanai A, Serizawa T, Sakamoto K, Akanuma M, Maeda S, Yamaji Y, Iwamoto Y, Kawazu S, Koike K. Gastric cancer diagnosed after Helicobacter pylori eradication in diabetes mellitus patients. BMC Gastroenterol. 2015;15:143. [PMID: 26486595 DOI: 10.1186/s12876-015-0377-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
39 Konuma H, Konuma I, Fu K, Yamada S, Suzuki Y, Miyazaki A. Youngest case of an early gastric cancer after successful eradication therapy. World J Gastrointest Endosc 2013; 5(6): 300-303 [PMID: 23772269 DOI: 10.4253/wjge.v5.i6.300] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
40 Bornschein J, Malfertheiner P. Gastric carcinogenesis. Langenbecks Arch Surg. 2011;396:729-742. [PMID: 21611816 DOI: 10.1007/s00423-011-0810-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
41 Bornschein J, Selgrad M, Wex T, Kuester D, Malfertheiner P. Serological assessment of gastric mucosal atrophy in gastric cancer. BMC Gastroenterol. 2012;12:10. [PMID: 22289789 DOI: 10.1186/1471-230x-12-10] [Cited by in Crossref: 47] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
42 Horiguchi N, Tahara T, Yamada H, Yoshida D, Okubo M, Nagasaka M, Nakagawa Y, Shibata T, Tsukamoto T, Kuroda M, Ohmiya N. In vivo diagnosis of early‐stage gastric cancer found after Helicobacter pylori eradication using probe‐based confocal laser endomicroscopy. Digestive Endoscopy 2018;30:219-27. [DOI: 10.1111/den.12926] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
43 Kodama M, Murakami K, Okimoto T, Sato R, Uchida M, Abe T, Shiota S, Nakagawa Y, Mizukami K, Fujioka T. Ten-year prospective follow-up of histological changes at five points on the gastric mucosa as recommended by the updated Sydney system after Helicobacter pylori eradication. J Gastroenterol. 2012;47:394-403. [PMID: 22138891 DOI: 10.1007/s00535-011-0504-9] [Cited by in Crossref: 69] [Cited by in F6Publishing: 59] [Article Influence: 6.3] [Reference Citation Analysis]
44 Abe S, Makiguchi ME, Nonaka S, Suzuki H, Yoshinaga S, Saito Y. Emerging texture and color enhancement imaging in early gastric cancer. Dig Endosc 2021. [PMID: 34716942 DOI: 10.1111/den.14182] [Reference Citation Analysis]
45 Ubukata H, Nagata H, Tabuchi T, Konishi S, Kasuga T, Tabuchi T. Why is the coexistence of gastric cancer and duodenal ulcer rare? Examination of factors related to both gastric cancer and duodenal ulcer. Gastric Cancer. 2011;14:4-12. [PMID: 21249411 DOI: 10.1007/s10120-011-0005-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
46 Kodama M, Okimoto T, Ogawa R, Mizukami K, Murakami K. Endoscopic atrophic classification before and after H. pylori eradication is closely associated with histological atrophy and intestinal metaplasia. Endosc Int Open. 2015;3:E311-E317. [PMID: 26357676 DOI: 10.1055/s-0034-1392090] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
47 Hwang YJ, Kim N, Lee HS, Lee JB, Choi YJ, Yoon H, Shin CM, Park YS, Lee DH. Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication - a prospective study for up to 10 years. Aliment Pharmacol Ther. 2018;47:380-390. [PMID: 29193217 DOI: 10.1111/apt.14424] [Cited by in Crossref: 74] [Cited by in F6Publishing: 54] [Article Influence: 14.8] [Reference Citation Analysis]
48 Akbari M, Tabrizi R, Kardeh S, Lankarani KB. Gastric cancer in patients with gastric atrophy and intestinal metaplasia: A systematic review and meta-analysis. PLoS One 2019;14:e0219865. [PMID: 31348819 DOI: 10.1371/journal.pone.0219865] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
49 Takata S, Ito M, Yoshihara M, Tanaka S, Imagawa S, Haruma K, Chayama K. Host factors contributing to the discovery of gastric cancer after successful eradication therapy of Helicobacter pylori: preliminary report. J Gastroenterol Hepatol. 2007;22:571-576. [PMID: 17376053 DOI: 10.1111/j.1440-1746.2006.04776.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
50 Wang J, Xu L, Shi R, Huang X, Li SW, Huang Z, Zhang G. Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication: a meta-analysis. Digestion. 2011;83:253-260. [PMID: 21282951 DOI: 10.1159/000280318] [Cited by in Crossref: 127] [Cited by in F6Publishing: 112] [Article Influence: 11.5] [Reference Citation Analysis]
51 Malfertheiner P, Selgrad M, Bornschein J. Helicobacter pylori: clinical management. Curr Opin Gastroenterol. 2012;28:608-614. [PMID: 23010682 DOI: 10.1097/mog.0b013e32835918a7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 16] [Article Influence: 4.1] [Reference Citation Analysis]
52 Tahara S, Tahara T, Tuskamoto T, Horiguchi N, Kawamura T, Okubo M, Ishizuka T, Nagasaka M, Nakagawa Y, Shibata T, Kuroda M, Ohmiya N. Morphologic characterization of residual DNA methylation in the gastric mucosa after Helicobacter pylori eradication. Cancer Med 2017;6:1730-7. [PMID: 28557342 DOI: 10.1002/cam4.1082] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
53 Sugano K. Long-term outcome and surveillance policy after endoscopic therapy for early gastric cancer. Gastric Cancer 2006;9:67-9. [DOI: 10.1007/s10120-006-0377-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
54 Yoshii S, Mabe K, Watano K, Ohno M, Matsumoto M, Ono S, Kudo T, Nojima M, Kato M, Sakamoto N. Validity of endoscopic features for the diagnosis of Helicobacter pylori infection status based on the Kyoto classification of gastritis. Dig Endosc. 2020;32:74-83. [PMID: 31309632 DOI: 10.1111/den.13486] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
55 Yee YK, Wong KW, Hui CK, Chan CK, Chan AO, Lam SK, Fung FM, Hung I, Wong BC. Prevalence and time trend of intestinal metaplasia in Hong Kong. J Gastroenterol Hepatol. 2009;24:896-899. [PMID: 19646018 DOI: 10.1111/j.1440-1746.2009.05799.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
56 Maehata Y, Nakamura S, Fujisawa K, Esaki M, Moriyama T, Asano K, Fuyuno Y, Yamaguchi K, Egashira I, Kim H, Kanda M, Hirahashi M, Matsumoto T. Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer. Gastrointest Endosc. 2012;75:39-46. [PMID: 22018552 DOI: 10.1016/j.gie.2011.08.030] [Cited by in Crossref: 122] [Cited by in F6Publishing: 120] [Article Influence: 11.1] [Reference Citation Analysis]
57 Horiguchi N, Tahara T, Kawamura T, Okubo M, Ishizuka T, Nakagawa Y, Nagasaka M, Shibata T, Ohmiya N. Distinct Clinic-Pathological Features of Early Differentiated-Type Gastric Cancers after Helicobacter pylori Eradication. Gastroenterol Res Pract 2016;2016:8230815. [PMID: 27212944 DOI: 10.1155/2016/8230815] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
58 Ito M, Tanaka S, Kamada T, Haruma K, Chayama K. Causal role of Helicobacter pylori infection and eradication therapy in gastric carcinogenesis. World J Gastroenterol 2006; 12(1): 10-16 [PMID: 16440410 DOI: 10.3748/wjg.v12.i1.10] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
59 Tahara T, Tahara S, Tuskamoto T, Horiguchi N, Kawamura T, Okubo M, Ishizuka T, Nagasaka M, Nakagawa Y, Shibata T, Kuroda M, Ohmiya N. Telomere length in the gastric mucosa after Helicobacter pylori eradication and its potential role in the gastric carcinogenesis. Clin Exp Med 2018;18:21-6. [DOI: 10.1007/s10238-017-0458-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
60 Sakitani K, Nishizawa T, Toyoshima A, Yoshida S, Matsuno T, Yamada T, Irokawa M, Takahashi Y, Nakai Y, Toyoshima O, Koike K. Kyoto classification in patients who developed multiple gastric carcinomas after Helicobacter pylori eradication. World J Gastrointest Endosc 2020; 12(9): 276-284 [PMID: 32994858 DOI: 10.4253/wjge.v12.i9.276] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
61 Chiba T, Marusawa H, Seno H, Watanabe N. Mechanism for gastric cancer development by Helicobacter pylori infection. J Gastroenterol Hepatol. 2008;23:1175-1181. [PMID: 18637055 DOI: 10.1111/j.1440-1746.2008.05472.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 4.1] [Reference Citation Analysis]
62 Bornschein J, Selgrad M, Warnecke M, Kuester D, Wex T, Malfertheiner P. H. pylori infection is a key risk factor for proximal gastric cancer. Dig Dis Sci. 2010;55:3124-3131. [PMID: 20668939 DOI: 10.1007/s10620-010-1351-x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 3.9] [Reference Citation Analysis]
63 Tahara T, Tahara S, Tuskamoto T, Horiguchi N, Yoshida D, Kawamura T, Okubo M, Nagasaka M, Nakagawa Y, Urano M, Kuroda M, Shibata T, Ohmiya N. Magnifying NBI Patterns of Gastric Mucosa After Helicobacter pylori Eradication and Its Potential Link to the Gastric Cancer Risk. Dig Dis Sci 2017;62:2421-7. [DOI: 10.1007/s10620-017-4676-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
64 Ikeda R, Hirasawa K, Sato C, Sawada A, Nishio M, Fukuchi T, Kobayashi R, Makazu M, Kaneko H, Maeda S. Incidence of metachronous gastric cancer after endoscopic submucosal dissection associated with eradication status of Helicobacter pylori. Eur J Gastroenterol Hepatol 2021;33:17-24. [PMID: 32483085 DOI: 10.1097/MEG.0000000000001788] [Reference Citation Analysis]
65 Tahara S, Tahara T, Horiguchi N, Kato T, Shinkai Y, Yamashita H, Yamada H, Kawamura T, Terada T, Okubo M, Nagasaka M, Nakagawa Y, Shibata T, Yamada S, Urano M, Tsukamoto T, Kurahashi H, Kuroda M, Ohmiya N. DNA methylation accumulation in gastric mucosa adjacent to cancer after Helicobacter pylori eradication. Int J Cancer 2019;144:80-8. [PMID: 29978464 DOI: 10.1002/ijc.31667] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
66 Takeuchi T, Higuchi K. Endoscopic Detection of Gastric Carcinoma After Helicobacter pylori Eradication: More Difficult or Just Hype? Dig Dis Sci 2016;61:1422-3. [PMID: 26984231 DOI: 10.1007/s10620-016-4106-5] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
67 Masuda K, Urabe Y, Ito M, Ono A, Clair Nelson H, Nakamura K, Kotachi T, Boda T, Tanaka S, Chayama K. Genomic landscape of epithelium with low-grade atypia on gastric cancer after Helicobacter pylori eradiation therapy. J Gastroenterol 2019;54:907-15. [PMID: 31197475 DOI: 10.1007/s00535-019-01596-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
68 Ito M, Tanaka S, Chayama K. Characteristics and Early Diagnosis of Gastric Cancer Discovered after Helicobacter pylori Eradication. Gut Liver 2021;15:338-45. [PMID: 32321202 DOI: 10.5009/gnl19418] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Eslick GD. Helicobacter pylori infection causes gastric cancer A? review of the epidemiological, meta-analytic, and experimental evidence. World J Gastroenterol 2006; 12(19): 2991-2999 [PMID: 16718777 DOI: 10.3748/wjg.v12.i19.2991] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 43] [Article Influence: 3.1] [Reference Citation Analysis]
70 Kishikawa H, Ojiro K, Nakamura K, Katayama T, Arahata K, Takarabe S, Miura S, Kanai T, Nishida J. Previous Helicobacter pylori infection-induced atrophic gastritis: A distinct disease entity in an understudied population without a history of eradication. Helicobacter. 2020;25:e12669. [PMID: 31680399 DOI: 10.1111/hel.12669] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
71 Miyaoka M, Yao K, Tanabe H, Kanemitsu T, Imamura K, Ono Y, Ohtsu K, Ishikawa S, Kojima T, Hasegawa R, Hirano A, Ikezono G, Hisabe T, Ueki T, Ota A, Haraoka S, Iwashita A. Usefulness of vessel plus surface classification system for the diagnosis of early gastric cancer after Helicobacter pylori eradication. Ann Gastroenterol 2021;34:354-60. [PMID: 33948060 DOI: 10.20524/aog.2021.0605] [Reference Citation Analysis]
72 Osawa H, Miura Y, Takezawa T, Ino Y, Khurelbaatar T, Sagara Y, Lefor AK, Yamamoto H. Linked Color Imaging and Blue Laser Imaging for Upper Gastrointestinal Screening. Clin Endosc 2018;51:513-26. [PMID: 30384402 DOI: 10.5946/ce.2018.132] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
73 Ito M, Takata S, Tatsugami M, Wada Y, Imagawa S, Matsumoto Y, Takamura A, Kitamura S, Matsuo T, Tanaka S, Haruma K, Chayama K. Clinical prevention of gastric cancer by Helicobacter pylori eradication therapy: a systematic review. J Gastroenterol 2009;44:365-71. [PMID: 19333542 DOI: 10.1007/s00535-009-0036-8] [Cited by in Crossref: 54] [Cited by in F6Publishing: 44] [Article Influence: 4.2] [Reference Citation Analysis]
74 Kato S, Shimizu T, Toyoda S, Gold BD, Ida S, Ishige T, Fujimura S, Kamiya S, Konno M, Kuwabara K, Ushijima K, Yoshimura N, Nakayama Y; Japanese Society for Pediatric Gastroenterology, Hepatology and Nutrition. The updated JSPGHAN guidelines for the management of Helicobacter pylori infection in childhood. Pediatr Int 2020;62:1315-31. [PMID: 32657507 DOI: 10.1111/ped.14388] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
75 Majima A, Dohi O, Takayama S, Hirose R, Inoue K, Yoshida N, Kamada K, Uchiyama K, Ishikawa T, Takagi T, Handa O, Konishi H, Naito Y, Itoh Y. Linked color imaging identifies important risk factors associated with gastric cancer after successful eradication of Helicobacter pylori. Gastrointest Endosc. 2019;90:763-769. [PMID: 31299258 DOI: 10.1016/j.gie.2019.06.043] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
76 Kimura K, Takemoto T. An Endoscopic Recognition of the Atrophic Border and its Significance in Chronic Gastritis. Endoscopy 1969;1:87-97. [DOI: 10.1055/s-0028-1098086] [Cited by in Crossref: 518] [Cited by in F6Publishing: 259] [Article Influence: 37.0] [Reference Citation Analysis]
77 Tucci A, Bisceglia M, Rugge M, Tucci P, Marchegiani A, Papadopoli G, Spada A, Villani A, Pennelli G, Fusaroli P, Caravelli G, Catalano T, Cennamo V, Cianci M, De Fanis C, Fabbri C, Feliciangeli G, Gizzi G, Spadaccini A, Caletti G. Clinical usefulness of gastric-juice analysis in 2007: the stone that the builders rejected has become the cornerstone. Gastrointest Endosc 2007;66:881-90. [PMID: 17963873 DOI: 10.1016/j.gie.2007.03.1052] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
78 Mizukami K, Ogawa R, Okamoto K, Shuto M, Fukuda K, Sonoda A, Matsunari O, Hirashita Y, Okimoto T, Kodama M, Murakami K. Objective Endoscopic Analysis with Linked Color Imaging regarding Gastric Mucosal Atrophy: A Pilot Study. Gastroenterol Res Pract 2017;2017:5054237. [PMID: 29270198 DOI: 10.1155/2017/5054237] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
79 Kodama M, Okimoto T, Mizukami K, Fukuda K, Ogawa R, Okamoto K, Matsunari O, Kawahara Y, Hirashita Y, Murakami K. Differences in Helicobacter pylori and CagA antibody changes after eradication between subjects developing and not developing gastric cancer. J Clin Biochem Nutr 2019;65:71-5. [PMID: 31379417 DOI: 10.3164/jcbn.19-30] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
80 Tahara T, Tahara S, Horiguchi N, Kawamura T, Okubo M, Nagasaka M, Nakagawa Y, Shibata T, Urano M, Tsukamoto T, Kuroda M, Ohmiya N. Gastric Mucosal Microarchitectures Associated with Irreversibility with Helicobacter pylori Eradication and Downregulation of Micro RNA (miR)-124a. Cancer Invest 2019;37:417-26. [PMID: 31483161 DOI: 10.1080/07357907.2019.1663207] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
81 Iijima K, Koike T, Sekine H, Abe Y, Asanuma K, Ara N, Uno K, Imatani A, Ohara S, Shimosegawa T. Sustained epithelial proliferation in a functionally irreversible fundic mucosa after Helicobacter pylori eradication. J Gastroenterol 2009;44:47-55. [PMID: 19159072 DOI: 10.1007/s00535-008-2270-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
82 Kitagawa Y, Suzuki T, Nankinzan R, Ishigaki A, Furukawa K, Sugita O, Hara T, Yamaguchi T. Comparison of endoscopic visibility and miss rate for early gastric cancers after Helicobacter pylori eradication with white-light imaging versus linked color imaging. Dig Endosc 2020;32:769-77. [PMID: 31765047 DOI: 10.1111/den.13585] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]